Boston Scientific's $3.7B Axonics Buy Under FTC Microscope - Law360 Healthcare Authority
Biomedical engineering company Boston Scientific Corp. on Thursday disclosed that the Federal Trade Commission requested more information on its planned $3.7 billion acquisition of medical technology company Axonics, which will result in a delay in the deal's closing. Law360 Healthcare Authority is investigating Boston Scientific's $3.7B Axonics Buy under FTC Microscope. The authority will send a verification email to your address before you can access your trial trial. Sign up for daily newsletters designed by senior editors to receive news and analysis in your area. Legal professionals may contact you in professional capacity to share information about our other products, services, and events that we believe may be of interest. We take our privacy seriously and make clear that our Privacy Policy is our own.
Published : a month ago by in Health
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Select at least one primary interest below to receive curated, daily newsletters designed by senior editors so you can quickly scan the latest news and analysis in your area of practice.
Law360 Healthcare Authority may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.
You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.
We take your privacy seriously. Please see our Privacy Policy.